NorthWest Biotherapeutics Inc (NWBO)

[Truthfan]

Of interest: link to join the presentation in body of INMB’s PR:

INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5, 2020

“Inflammation is a key element to the pathology seen in patients with COVID-19.  Any treatment that targets the complications of COVID-19 should somehow explain why hypertension and obesity are such important risk factors to hospitalization from this vexing disease,” said RJ Tesi. “We believe endothelial activation caused by soluble TNF is an unrecognized driver of the disease.  Patients with hypertension and obesity already have inflamed endothelial cells.  With the added stimulus of the cytokine storm, the response is dramatic.  We believe targeting sTNF is the ideal anti-cytokine therapy for treating the complications of COVID-19 as it targets inflammation without immunosuppressing the host.”

https://www.inmunebio.com/index.php/en/news-2/2020/324-muneionctopeakon19herapeuticanelat20200428